De Novo-Designed Minibinders Expand the Synthetic Biology Sensing Repertoire for Engineered Cell Therapies
De novo-designed minibinders can be readily adapted as antigen sensors across diverse synthetic receptor platforms, including proteolytic receptors and chimeric antigen receptors, enabling expanded sensing capabilities for engineered cell therapies.